Cyteir Therapeutics Inc

NASDAQ:CYT   3:59:50 PM EDT
1.64
+0.02 (+0.92%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Cyteir Therapeutics Inc Stock, NASDAQ:CYT

128 Spring Street, Building A, Lexington, Massachusetts 02421
United States of America
Phone: +1.857.285.4140
Number of Employees: 40

Description

Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA.